Cases 21 - 30 of 914
SMITH v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv03754
Plaintiff:
KIM SMITH
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DAVISON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03279
Plaintiff:
BRUCE DAVISON
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BUXTON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02933
Plaintiff:
DIXIE B BUXTON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MERRILL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02857
Plaintiff:
DOUGLAS MERRILL
Defendant:
AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al
as 1:2023cv00556
Plaintiff:
Mylan Pharmaceuticals Inc.
Defendant:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
MYLAN PHARMACEUTICALS INC. et al v. SANOFI-AVENTIS U.S. LLC et al
as 2:2023cv00836
Plaintiff:
MYLAN PHARMACEUTICALS INC., MYLAN SPECIALTY L.P. and MYLAN INC.
Defendant:
SANOFI-AVENTIS U.S. LLC, SANOFI S.A., AVENTIS PHARMA S.A. and others
Cause Of Action: 15 U.S.C. § 2 Antitrust Litigation
LIER v. MYLAN LABORATORIES LTD. et al
as 1:2023cv02589
Plaintiff:
HAN LIER
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WESSON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02342
Plaintiff:
EMMETT WESSON
Defendant:
AUROBINDO PHARMA LTD., HETERO DRUGS LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DAWSON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv01159
Plaintiff:
DIANA DAWSON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN, N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In Re: Valsartan Losartan and Irbesartan Products
as 23-8007
Petitioner:
AUROBINDO PHARMA LTD, AUROBINDO PHARMA USA INC, AUROLIFE PHARMA LLC and others
Respondent:
CONSUMER ECONOMIC LOSS PLAINTIFFS, THIRD-PARTY PAYOR PLAINTIFFS and MEDICAL MONITORING PLAINTIFFS
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
